Trump just eased restrictions on marijuana on a national level—here is what that actually means

In a potentially historic shift, the Trump administration has moved forward with reclassifying cannabis as a Schedule III drug. 

Although the change does not legalize marijuana at the federal level, it signals that it is considered less dangerous than previously classified (it was, until now, grouped alongside drugs like heroin). To be clear: marijuana for medical or recreational use is still considered illegal under federal law, but its shift from Schedule I (basically drugs without medical use and a high potential for abuse) to Schedule III makes it less strictly regulated. The change also gives a major tax break to licensed operators and increases the ability to do research. 

“This rescheduling action allows for research on the safety and efficacy of this substance, ultimately providing patients with better care and doctors with more reliable information," said Acting Attorney General Todd Blanche in an official statement. 

What makes this particularly notable is how it intersects with the current reality on the ground: marijuana is already legal for medical and/or recreational use in dozens of states, from New York to California. Until now, that created a strange legal gray zone: state-sanctioned industries operating in direct conflict with federal law. Reclassification doesn’t erase that contradiction, but it does soften it, offering something closer to tacit federal acknowledgment of the legal markets that already exist.

For those states, the impact could be tangible. Cannabis businesses have long been locked out of traditional banking systems and weighed down by punitive federal tax rules. Now, the may get some relief, making it easier to operate like legitimate enterprises.

Still, the bigger picture remains unresolved: critics point to full federal legalization, interstate commerce and criminal justice reform as key components of the conversation that have yet to be addressed.